Učitavanje...

Emerging biomarkers in the diagnosis of prostate cancer

Prostate cancer (PCa) is the second most common cancer in men worldwide. A large proportion of PCa are latent, never destined to progress or affect the patients’ life. It is of utmost importance to identify which PCa are destined to progress and which would benefit from an early radical treatment. P...

Cijeli opis

Spremljeno u:
Bibliografski detalji
Izdano u:Pharmgenomics Pers Med
Glavni autori: Filella, Xavier, Fernández-Galan, Esther, Fernández Bonifacio, Rosa, Foj, Laura
Format: Artigo
Jezik:Inglês
Izdano: Dove Medical Press 2018
Teme:
Online pristup:https://ncbi.nlm.nih.gov/pmc/articles/PMC5961643/
https://ncbi.nlm.nih.gov/pubmed/29844697
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/PGPM.S136026
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!